Gene expression profiles of the NCI-60 human tumor cell lines define molecular interaction networks governing cell migration processes

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Kohn, Kurt W ^a   Zeeberg, Barry R ^a   Reinhold, William C ^a   Sunshine, Margot ^a   Luna, Augustin ^a   Pommier, Yves ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; INTEGRIN; MESSENGER RNA;

ADAM9 GENE; AMOTL2 GENE; ARTICLE; AXL GENE; CAPN2 GENE; CD151 GENE; CELL INTERACTION; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; CYTOSKELETON; EGFR GENE; EPITHELIAL MESENCHYMAL TRANSITION; FLNA GENE; FN19 GENE; GENE CLUSTER; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE MAPPING; HUMAN; HUMAN CELL; ITGB1 GENE; LOXL2 GENE; METASTASIS; MOLECULAR INTERACTION; MYH9 GENE; RRAS GENE; THBS1 GENE; TRIO GENE; TRPC1 GENE; TUMOR CELL LINE; TUMOR GENE; UPREGULATION; VCL GENE;

ACTINS; CALCIUM; CALPAIN; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL MEMBRANE; CELL MOVEMENT; CLUSTER ANALYSIS; EPITHELIAL-MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; HUMANS; INTEGRINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; PROTEIN INTERACTION MAPS; PROTO-ONCOGENE PROTEINS; RAS PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; TRANSCRIPTOME;

EID: 84860504667     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0035716     Document Type: Article

References (91)

1. Ross DT, Scherf U, Eisen MB, Perou CM, Rees C, et al. (2000) Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet 24: 227-235.
2. Scherf U, Ross DT, Waltham M, Smith LH, Lee JK, et al. (2000) A gene expression database for the molecular pharmacology of cancer. Nat Genet 24: 236-244.
3. Liu H, D'Andrade P, Fulmer-Smentek S, Lorenzi P, Kohn KW, et al. (2010) mRNA and microRNA expression profiles of the NCI-60 integrated with drug activities. Mol Cancer Ther 9: 1080-1091.
4. Park SM, Gaur AB, Lengyel E, Peter ME, (2008) The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 22: 894-907.
5. Weinstein JN, (2004) Integromic analysis of the NCI-60 cancer cell lines. Breast Dis 19: 11-22.
6. Weinstein JN, (2006) Spotlight on molecular profiling: "Integromic" analysis of the NCI-60 cancer cell lines. Mol Cancer Ther 5: 2601-2605.
7. Shankavaram UT, Reinhold WC, Nishizuka S, Major S, Morita D, et al. (2007) Transcript and protein expression profiles of the NCI-60 cancer cell panel: an integromic microarray study. Mol Cancer Ther 6: 820-832.
8. Reinhold WC, Erliandri I, Liu H, Zoppoli G, Pommier Y, et al. (2011) Identification of a predominant co-regulation among kinetochore genes, prospective regulatory elements, and association with genomic instability. PLoS One 6: e25991.
9. Zeeberg BR, Reinhold W, Snajder R, Thallinger GG, Weinstein JN, et al. (2012) Functional Categories Associated with Clusters of Genes That Are Co-Expressed across the NCI-60 Cancer Cell Lines. PLoS ONE 7: e30317.
10. Hanahan D, Weinberg RA, (2011) Hallmarks of cancer: the next generation. Cell 144: 646-674.
11. Vicente-Manzanares M, Horwitz AR, (2011) Cell migration: an overview. Methods Mol Biol 769: 1-24.
12. Kohn KW, (1999) Molecular interaction map of the mammalian cell cycle control and DNA repair systems. Mol Biol Cell 10: 2703-2734.
13. Kohn KW, Aladjem MI, Weinstein JN, Pommier Y, (2006) Molecular interaction maps of bioregulatory networks: a general rubric for systems biology. Mol Biol Cell 17: 1-13.
14. Shankavaram UT, Varma S, Kane D, Sunshine M, Chary KK, et al. (2009) CellMiner: a relational database and query tool for the NCI-60 cancer cell lines. BMC Genomics 10: 277.
15. Zeeberg BR, Qin H, Narasimhan S, Sunshine M, Cao H, et al. (2005) High-Throughput GoMiner, an 'industrial-strength' integrative gene ontology tool for interpretation of multiple-microarray experiments, with application to studies of Common Variable Immune Deficiency (CVID). BMC Bioinformatics 6: 168.
16. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, et al. (2000) Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25: 25-29.
17. GO-project (2006) The Gene Ontology (GO) project in 2006. Nucleic Acids Res 34: D322-326.
18. Eyre TA, Ducluzeau F, Sneddon TP, Povey S, Bruford EA, et al. (2006) The HUGO Gene Nomenclature Database, 2006 updates. Nucleic Acids Res 34: D319-321.
19. Luna A, Sunshine ML, van Iersel MP, Aladjem MI, Kohn KW, (2011) PathVisio-MIM: PathVisio plugin for creating and editing Molecular Interaction Maps (MIMs). Bioinformatics 27: 2165-2166.
20. McHugh BJ, Buttery R, Lad Y, Banks S, Haslett C, et al. (2010) Integrin activation by Fam38A uses a novel mechanism of R-Ras targeting to the endoplasmic reticulum. J Cell Sci 123: 51-61.
21. Conklin MW, Ada-Nguema A, Parsons M, Riching KM, Keely PJ, (2010) R-Ras regulates beta1-integrin trafficking via effects on membrane ruffling and endocytosis. BMC Cell Biol 11: 14.
22. Wozniak MA, Kwong L, Chodniewicz D, Klemke RL, Keely PJ, (2005) R-Ras controls membrane protrusion and cell migration through the spatial regulation of Rac and Rho. Mol Biol Cell 16: 84-96.
23. Wei C, Wang X, Zheng M, Cheng H, (2011) Calcium gradients underlying cell migration. Curr Opin Cell Biol 24: 1-8.
24. Shang X, Cancelas JA, Li L, Guo F, Liu W, et al. (2011) R-Ras and Rac GTPase cross-talk regulates hematopoietic progenitor cell migration, homing, and mobilization. J Biol Chem 286: 24068-24078.
25. Holly SP, Larson MK, Parise LV, (2005) The unique N-terminus of R-ras is required for Rac activation and precise regulation of cell migration. Mol Biol Cell 16: 2458-2469.
26. Gawecka JE, Griffiths GS, Ek-Rylander B, Ramos JW, Matter ML, (2010) R-Ras regulates migration through an interaction with filamin A in melanoma cells. PLoS One 5: e11269.
27. Goldfinger LE, Ptak C, Jeffery ED, Shabanowitz J, Hunt DF, et al. (2006) RLIP76 (RalBP1) is an R-Ras effector that mediates adhesion-dependent Rac activation and cell migration. J Cell Biol 174: 877-888.
28. Coon BG, Burgner J, Camonis JH, Aguilar RC, (2010) The epsin family of endocytic adaptors promotes fibrosarcoma migration and invasion. J Biol Chem 285: 33073-33081.
29. Ambudkar IS, Ong HL, Liu X, Bandyopadhyay BC, Cheng KT, (2007) TRPC1: the link between functionally distinct store-operated calcium channels. Cell Calcium 42: 213-223.
30. Prevarskaya N, Skryma R, Shuba Y, (2011) Calcium in tumour metastasis: new roles for known actors. Nat Rev Cancer 11: 609-618.
31. Cheng KT, Liu X, Ong HL, Swaim W, Ambudkar IS, (2011) Local Ca(2)+ entry via Orai1 regulates plasma membrane recruitment of TRPC1 and controls cytosolic Ca(2)+ signals required for specific cell functions. PLoS Biol 9: e1001025.
32. Bouquier N, Vignal E, Charrasse S, Weill M, Schmidt S, et al. (2009) A cell active chemical GEF inhibitor selectively targets the Trio/RhoG/Rac1 signaling pathway. Chem Biol 16: 657-666.
33. Salhia B, Tran NL, Chan A, Wolf A, Nakada M, et al. (2008) The guanine nucleotide exchange factors trio, Ect2, and Vav3 mediate the invasive behavior of glioblastoma. Am J Pathol 173: 1828-1838.
34. Riggins RB, Quilliam LA, Bouton AH, (2003) Synergistic promotion of c-Src activation and cell migration by Cas and AND-34/BCAR3. J Biol Chem 278: 28264-28273.
35. Carisey A, Ballestrem C, (2011) Vinculin, an adapter protein in control of cell adhesion signalling. Eur J Cell Biol 90: 157-163.
36. Parri M, Chiarugi P, (2010) Rac and Rho GTPases in cancer cell motility control. Cell Commun Signal 8: 23.
37. Tai KY, Shieh YS, Lee CS, Shiah SG, Wu CW, (2008) Axl promotes cell invasion by inducing MMP-9 activity through activation of NF-kappaB and Brg-1. Oncogene 27: 4044-4055.
38. Fry JL, Toker A, (2010) Secreted and membrane-bound isoforms of protease ADAM9 have opposing effects on breast cancer cell migration. Cancer Res 70: 8187-8198.
39. Mahimkar RM, Visaya O, Pollock AS, Lovett DH, (2005) The disintegrin domain of ADAM9: a ligand for multiple beta1 renal integrins. Biochem J 385: 461-468.
40. Dang M, Dubbin K, D'Aiello A, Hartmann M, Lodish H, et al. (2011) Epidermal growth factor (EGF) ligand release by substrate-specific a disintegrin and metalloproteases (ADAMs) involves different protein kinase C (PKC) isoenzymes depending on the stimulus. J Biol Chem 286: 17704-17713.
41. Edwards DR, Handsley MM, Pennington CJ, (2008) The ADAM metalloproteinases. Mol Aspects Med 29: 258-289.
42. Fritzsche FR, Wassermann K, Jung M, Tolle A, Kristiansen I, et al. (2008) ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression. BMC Cancer 8: 179.
43. Zigrino P, Steiger J, Fox JW, Loffek S, Schild A, et al. (2007) Role of ADAM-9 disintegrin-cysteine-rich domains in human keratinocyte migration. J Biol Chem 282: 30785-30793.
44. Mazzocca A, Coppari R, De Franco R, Cho JY, Libermann TA, et al. (2005) A secreted form of ADAM9 promotes carcinoma invasion through tumor-stromal interactions. Cancer Res 65: 4728-4738.
45. Gustafsson A, Martuszewska D, Johansson M, Ekman C, Hafizi S, et al. (2009) Differential expression of Axl and Gas6 in renal cell carcinoma reflecting tumor advancement and survival. Clin Cancer Res 15: 4742-4749.
46. Hafizi S, Dahlback B, (2006) Signalling and functional diversity within the Axl subfamily of receptor tyrosine kinases. Cytokine Growth Factor Rev 17: 295-304.
47. Rankin EB, Fuh KC, Taylor TE, Krieg AJ, Musser M, et al. (2010) AXL is an essential factor and therapeutic target for metastatic ovarian cancer. Cancer Res 70: 7570-7579.
48. Dolznig H, Rupp C, Puri C, Haslinger C, Schweifer N, et al. (2011) Modeling colon adenocarcinomas in vitro a 3D co-culture system induces cancer-relevant pathways upon tumor cell and stromal fibroblast interaction. Am J Pathol 179: 487-501.
49. Sotgia F, Martinez-Outschoorn UE, Howell A, Pestell RG, Pavlides S, et al. (2012) Caveolin-1 and Cancer Metabolism in the Tumor Microenvironment: Markers, Models, and Mechanisms. Annu Rev Pathol pp. 423-467.
50. Linger RM, Keating AK, Earp HS, Graham DK, (2010) Taking aim at Mer and Axl receptor tyrosine kinases as novel therapeutic targets in solid tumors. Expert Opin Ther Targets 14: 1073-1090.
51. Gjerdrum C, Tiron C, Hoiby T, Stefansson I, Haugen H, et al. (2010) Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival. Proc Natl Acad Sci U S A 107: 1124-1129.
52. Hafizi S, Dahlback B, (2006) Gas6 and protein S. Vitamin K-dependent ligands for the Axl receptor tyrosine kinase subfamily. FEBS J 273: 5231-5244.
53. Winkles JA, (2008) The TWEAK-Fn14 cytokine-receptor axis: discovery, biology and therapeutic targeting. Nat Rev Drug Discov 7: 411-425.
54. Donohue PJ, Richards CM, Brown SA, Hanscom HN, Buschman J, et al. (2003) TWEAK is an endothelial cell growth and chemotactic factor that also potentiates FGF-2 and VEGF-A mitogenic activity. Arterioscler Thromb Vasc Biol 23: 594-600.
55. Chorianopoulos E, Heger T, Lutz M, Frank D, Bea F, et al. (2010) FGF-inducible 14-kDa protein (Fn14) is regulated via the RhoA/ROCK kinase pathway in cardiomyocytes and mediates nuclear factor-kappaB activation by TWEAK. Basic Res Cardiol 105: 301-313.
56. Page RE, Klein-Szanto AJ, Litwin S, Nicolas E, Al-Jumaily R, et al. (2007) Increased expression of the pro-protein convertase furin predicts decreased survival in ovarian cancer. Cell Oncol 29: 289-299.
57. Polavarapu R, Gongora MC, Winkles JA, Yepes M, (2005) Tumor necrosis factor-like weak inducer of apoptosis increases the permeability of the neurovascular unit through nuclear factor-kappa B pathway activation. J Neurosci 25: 10094-10100.
58. Haile WB, Echeverry R, Wu F, Guzman J, An J, et al. (2010) Tumor necrosis factor-like weak inducer of apoptosis and fibroblast growth factor-inducible 14 mediate cerebral ischemia-induced poly(ADP-ribose) polymerase-1 activation and neuronal death. Neuroscience.
59. Alam N, Goel HL, Zarif MJ, Butterfield JE, Perkins HM, et al. (2007) The integrin-growth factor receptor duet. J Cell Physiol 213: 649-653.
60. Zaidel-Bar R, Geiger B, (2010) The switchable integrin adhesome. J Cell Sci 123: 1385-1388.
61. Zevian S, Winterwood NE, Stipp CS, (2011) Structure-function analysis of tetraspanin CD151 reveals distinct requirements for tumor cell behaviors mediated by alpha3beta1 versus alpha6beta4 integrin. J Biol Chem 286: 7496-7506.
62. Devbhandari RP, Shi GM, Ke AW, Wu FZ, Huang XY, et al. (2011) Profiling of the tetraspanin CD151 web and conspiracy of CD151/integrin beta1 complex in the progression of hepatocellular carcinoma. PLoS One 6: e24901.
63. Shi GM, Ke AW, Zhou J, Wang XY, Xu Y, et al. (2010) CD151 modulates expression of matrix metalloproteinase 9 and promotes neoangiogenesis and progression of hepatocellular carcinoma. Hepatology 52: 183-196.
64. Barker HE, Chang J, Cox TR, Lang G, Bird D, et al. (2011) LOXL2-mediated matrix remodeling in metastasis and mammary gland involution. Cancer Res 71: 1561-1572.
65. Schietke R, Warnecke C, Wacker I, Schodel J, Mole DR, et al. (2010) The lysyl oxidases LOX and LOXL2 are necessary and sufficient to repress E-cadherin in hypoxia: insights into cellular transformation processes mediated by HIF-1. J Biol Chem 285: 6658-6669.
66. Wang W, Huang J, Chen J, (2011) Angiomotin-like proteins associate with and negatively regulate YAP1. J Biol Chem 286: 4364-4370.
67. Xu MZ, Chan SW, Liu AM, Wong KF, Fan ST, et al. (2010) AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma. Oncogene.
68. Morello V, Cabodi S, Sigismund S, Camacho-Leal MP, Repetto D, et al. (2011) beta1 integrin controls EGFR signaling and tumorigenic properties of lung cancer cells. Oncogene 30: 4087-4096.
69. Staniszewska I, Zaveri S, Del Valle L, Oliva I, Rothman VL, et al. (2007) Interaction of alpha9beta1 integrin with thrombospondin-1 promotes angiogenesis. Circ Res 100: 1308-1316.
70. John AS, Rothman VL, Tuszynski GP, (2010) Thrombospondin-1 (TSP-1) Stimulates Expression of Integrin alpha6 in Human Breast Carcinoma Cells: A Downstream Modulator of TSP-1-Induced Cellular Adhesion. J Oncol 2010 645376.
71. Goicoechea S, Orr AW, Pallero MA, Eggleton P, Murphy-Ullrich JE, (2000) Thrombospondin mediates focal adhesion disassembly through interactions with cell surface calreticulin. J Biol Chem 275: 36358-36368.
72. Goicoechea S, Pallero MA, Eggleton P, Michalak M, Murphy-Ullrich JE, (2002) The anti-adhesive activity of thrombospondin is mediated by the N-terminal domain of cell surface calreticulin. J Biol Chem 277: 37219-37228.
73. Yan Q, Murphy-Ullrich JE, Song Y, (2010) Structural insight into the role of thrombospondin-1 binding to calreticulin in calreticulin-induced focal adhesion disassembly. Biochemistry 49: 3685-3694.
74. Yan Q, Murphy-Ullrich JE, Song Y, (2011) Molecular and structural insight into the role of key residues of thrombospondin-1 and calreticulin in thrombospondin-1-calreticulin binding. Biochemistry 50: 566-573.
75. Kim J, Kim C, Kim TS, Bang SI, Yang Y, et al. (2006) IL-18 enhances thrombospondin-1 production in human gastric cancer via JNK pathway. Biochem Biophys Res Commun 344: 1284-1289.
76. Faye C, Chautard E, Olsen BR, Ricard-Blum S, (2009) The first draft of the endostatin interaction network. J Biol Chem 284: 22041-22047.
77. Blake SM, Strasser V, Andrade N, Duit S, Hofbauer R, et al. (2008) Thrombospondin-1 binds to ApoER2 and VLDL receptor and functions in postnatal neuronal migration. EMBO J 27: 3069-3080.
78. Kunishima S, Saito H, (2010) Advances in the understanding of MYH9 disorders. Curr Opin Hematol 17: 405-410.
79. Johnstone DB, Zhang J, George B, Leon C, Gachet C, et al. (2011) Podocyte-specific deletion of Myh9 encoding nonmuscle myosin heavy chain 2A predisposes mice to glomerulopathy. Mol Cell Biol 31: 2162-2170.
80. Bagorda A, Mihaylov VA, Parent CA, (2006) Chemotaxis: moving forward and holding on to the past. Thromb Haemost 95: 12-21.
81. Liu L, Parent CA, (2011) Review series: TOR kinase complexes and cell migration. J Cell Biol 194: 815-824.
82. Broussard JA, Webb DJ, Kaverina I, (2008) Asymmetric focal adhesion disassembly in motile cells. Curr Opin Cell Biol 20: 85-90.
83. Liang S, He L, Zhao X, Miao Y, Gu Y, et al. (2011) MicroRNA let-7f inhibits tumor invasion and metastasis by targeting MYH9 in human gastric cancer. PLoS One 6: e18409.
84. Cavet ME, Smolock EM, Menon P, Konishi A, Korshunov VA, et al. (2010) Gas6-Axl pathway: the role of redox-dependent association of Axl with nonmuscle myosin IIB. Hypertension 56: 105-111.
85. Huber MA, Kraut N, Beug H, (2005) Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 17: 548-558.
86. Vuoriluoto K, Haugen H, Kiviluoto S, Mpindi JP, Nevo J, et al. (2010) Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer. Oncogene.
87. Thomson S, Petti F, Sujka-Kwok I, Mercado P, Bean J, et al. (2011) A systems view of epithelial-mesenchymal transition signaling states. Clin Exp Metastasis 28: 137-155.
88. Egeblad M, Nakasone ES, Werb Z, (2010) Tumors as organs: complex tissues that interface with the entire organism. Dev Cell 18: 884-901.
89. Giannone G, Ronde P, Gaire M, Beaudouin J, Haiech J, et al. (2004) Calcium rises locally trigger focal adhesion disassembly and enhance residency of focal adhesion kinase at focal adhesions. J Biol Chem 279: 28715-28723.
90. Ingolia NT, Ghaemmaghami S, Newman JR, Weissman JS, (2009) Genome-wide analysis in vivo of translation with nucleotide resolution using ribosome profiling. Science 324: 218-223.
91. Ingolia NT, Lareau LF, Weissman JS, (2011) Ribosome profiling of mouse embryonic stem cells reveals the complexity and dynamics of mammalian proteomes. Cell 147: 789-802.